Free Trial

Maze Therapeutics (MAZE) Institutional Ownership

Maze Therapeutics logo
$10.85 +0.26 (+2.46%)
As of 05/2/2025 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Maze Therapeutics (NASDAQ:MAZE)

Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$43.49M
Number of
Institutional Sellers
(last 12 months)
0
Get MAZE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Maze Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

MAZE Institutional Buying and Selling by Quarter

Maze Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/2/2025Alphabet Inc.2,412,471$26.56M1.7%N/A5.508%
5/1/2025 New York State Common Retirement Fund2,300$25K0.0%N/A0.005%
4/29/2025 Bank of New York Mellon Corp17,233$190K0.0%N/A0.039%
4/23/2025 Bessemer Group Inc.481,790$5.31M0.0%N/A1.100%
4/16/2025 General Catalyst Group Management LLC1,035,910$11.41M1.3%N/A2.365%
(Data available from 1/1/2016 forward)

MAZE Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of MAZE shares?

During the previous two years, the following institutional investors and hedge funds held shares of Maze Therapeutics shares: Alphabet Inc. ($26.56M), General Catalyst Group Management LLC ($11.41M), Bessemer Group Inc. ($5.31M), and Bank of New York Mellon Corp ($190K), New York State Common Retirement Fund ($25K).Learn more on MAZE's institutional investors.

Which institutional investors have been buying Maze Therapeutics stock?

The following institutional investors have purchased Maze Therapeutics stock in the last 24 months: Alphabet Inc. ($2.41M), General Catalyst Group Management LLC ($1.04M), Bessemer Group Inc. ($481.79K), Bank of New York Mellon Corp ($17.23K), and New York State Common Retirement Fund ($2.30K).

How much institutional buying is happening at Maze Therapeutics?

Institutional investors have bought a total of 3,949,704 shares in the last 24 months. This purchase volume represents approximately $43.49M in transactions.



This page (NASDAQ:MAZE) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners